domingo, 23 de mayo de 2010

Ranibizumab Effective in Diabetic Macular Edema

May 7, 2010 — Intravitreal ranibizumab (Lucentis; Genentech), in combination with laser treatment, is more effective than triamcinolone and laser alone for the treatment of diabetic macular edema (DME) involving the central macula, according to the findings of a randomized trial published online April 27 in Ophthalmology and presented at a teleconference held by the National Eye Institute.

Ver mas:

2 comentarios:

  1. Yo he leido que muchos pacientes diabeticos pueden ser victimas de osteoartritis y otras enfermedades reumaticas, a mi por ejemplo me ayuda mucho lo que comentan en este blog

  2. This is a helpful post. Very informative. Thank you for sharing your post.

    Macular Edema